CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
Albumin platelet-rich fibrin +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07363135
NCT07363135N/ACompleted

Evaluation of Albumin Platelet-Rich Fibrin Application Following Scaling and Root Planing on Gingival Crevicular Fluid Growth Factors in Patients With Periodontitis

Saglik Bilimleri Universitesi·interventional·Posted Jan 23, 2026·Updated Feb 17, 2026

In Brief

A clinical study evaluating Albumin platelet-rich fibrin and Sterile saline (0.9%) for Periodontitis and Periodontitis (Stage 3). Completed, enrolled 23 participants across 1 site.

Detailed Summary

The study aims to investigate whether application of albumin platelet-rich fibrin (Alb-PRF) into the gum pockets after scaling and root planing (SRP) can improve healing in patients with Stage III Grade B periodontitis. Periodontitis is a chronic disease that damages the tissues and bone surrounding the teeth and can lead to tooth loosening or loss if untreated. SRP is the first and most important treatment step, cleaning the tooth surfaces and smoothing the roots to reduce inflammation, but healing is often limited. PRF, made from the patient's own blood, is rich in platelets and growth factors that support tissue repair, and Alb-PRF is a new form that stays longer in the pocket and releases growth factors over time. In this study, 23 patients who meet the inclusion criteria (adults without systemic diseases, not using medications, non-smokers, not pregnant or breastfeeding, and not recently treated for periodontitis) will participate in a split-mouth design, where one side of the mouth receives SRP+ Alb-PRF and the other side receives SRP alone. Clinical measurements, including plaque, gum inflammation, bleeding, pocket depth, gum recession, and attachment levels, will be taken at baseline, 3 months, and 6 months, while X-rays will assess bone defects at baseline and 6 months. Additionally, gingival crevicular fluid (GCF) will be collected from the deepest pockets at baseline and on days 7, 14, and 21 to measure growth factors in the laboratory. Blood from patients will be processed to prepare the albumin-PRF gel, which will be carefully applied to the deep pockets on the test side. The investigators expect that pockets treated with albumin-PRF gel will show greater clinical attachment gain and higher, longer-lasting growth factor levels, potentially leading to improved gum and bone healing compared to SRP alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)

Timeline

N/ACompletedFinished
20252026
First PostedJan 23, 2026
Enrollment StartNov 20, 2024
Primary CompletionOct 15, 2025
Study CompletionFeb 1, 2026
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5 months ago

Interventions

Albumin platelet-rich fibrinprocedure

Application of Alb-PRF to the periodontal pockets in the test sites.

Sterile saline (0.9%)other

Control sites received a sham intervention consisting of sterile saline solution irrigation into the periodontal pockets, to mimic the procedural aspects of PRF placement without delivering any biologically active material.